Jungmin Kim

JungMin Kim is a Senior Principal Scientist at Bristol Myers Squibb since November 2019, specializing in protein and cytokine engineering, drug discovery, and project leadership. Prior to this role, JungMin held positions as Principal Scientist at Celgene and Senior Scientist at both Celgene and Delinia, focusing on protein engineering and discovery. Previous experience includes a Scientist role at Compugen Inc., and a postdoctoral position at the University of California, San Francisco, where efforts centered on phage display techniques and antibody characterization methods. JungMin's academic foundation includes a Ph.D. in Molecular Genetics and a B.Sc. in Biochemistry from the University of Toronto, with research experience spanning various protein interactions and purification methods.